Interesting study coverage from Wired magazine, of all places

Of course, Wired tends to be concerned with technology primarily and I think I've subscribed since their earliest beginnings,
but here's their coverage of this new study being conducted at Scripp Research looking for subjects to try out a GLP-1 drug as a possible treatment due to its anti-inflammatory properties:
https://www.wired.com/story/weight-loss-drug-zepbound-is-being-tested-as-a-treatment-for-long-covid/
If many people find they're blocked by a paywall, please comment and I'll just pirate post the text below.